You can get medication for anxiety or depression by scheduling an appointment with a primary care doctor, psychiatrist, nurse practitioner, or physician assistant. Most people start with their regular doctor, who can screen you with a brief questionnaire, make a diagnosis, and write a prescription during that same visit. The process is more straightforward than many people expect, but which provider you see, which medication you’re started on, and how closely you’re monitored all shape how well treatment goes.
Who Can Prescribe and How They Differ
The most common entry point is a primary care physician. PCPs prescribe the majority of antidepressants and anti-anxiety medications in the United States, and for mild to moderate symptoms, outcomes are comparable to psychiatric care. One study of managed-care patients found that the proportion receiving an adequate dose of antidepressant for at least 90 days was virtually identical whether the prescriber was a psychiatrist or a primary care doctor (roughly half in each group), and both groups showed similar rates of symptom improvement.1PubMed. Treatment Process and Outcomes for Managed Care Patients Receiving New Antidepressant Prescriptions From Psychiatrists and Primary Care Physicians The practical difference was follow-up frequency: psychiatrists’ patients averaged more visits in the first 90 days.
Psychiatrists are physicians who specialize in mental health. They tend to recommend medication more often, especially in combination with counseling. In a comparison of how the two groups approached mild depression, psychiatrists were more likely to recommend an antidepressant (about 70% versus 56% of primary care doctors) and far more likely to suggest combined medication and counseling.2PubMed Central. Primary care physicians’ and psychiatrists’ approaches to treating mild depression If your symptoms are severe, if you’ve tried multiple medications without success, or if you have a complex mix of conditions, a psychiatrist is the better fit.
Nurse practitioners and physician assistants can also prescribe psychiatric medications. NPs have been taking on a growing share of mental health prescribing, and in community health centers, NPs actually prescribed antidepressants at a slightly higher rate than physicians.3PubMed Central. The Effectiveness of Nurse Practitioner Care for Patients with Mental Health Conditions in Primary Care Settings: A Systematic Review For Medicaid-insured youth specifically, the share of psychotropic prescriptions written by NPs has been climbing while the physician share has been declining.4PubMed. Comparing Nurse Practitioner and Physician Prescribing of Psychotropic Medications for Medicaid-Insured Youths In practical terms, if you’re having trouble getting a psychiatry appointment (wait times of weeks or months are common), a psychiatric nurse practitioner is a well-qualified alternative.
What Happens at the First Appointment
Your provider will ask you about your symptoms, how long they’ve been going on, and how much they interfere with your daily life. Most will also have you fill out a short screening questionnaire. The two most common are the PHQ-9 for depression and the GAD-7 for anxiety. These are not diagnostic tests on their own, but they help your provider gauge severity and track your progress over time.
In general practice settings, the PHQ-9 has shown strong sensitivity for detecting depression (around 89% in one diagnostic accuracy study), meaning it catches most cases.5Journal of Heart Valve Disease. Assessment of Mental Health Screening Tools in General Practice for Early Detection of Depression and Anxiety Disorders: A Diagnostic Accuracy Study The GAD-7 performs similarly for anxiety and also functions as a reasonable screen across several types of anxiety disorders, not just generalized anxiety.6PubMed. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection You should answer these honestly. There’s no benefit to downplaying symptoms, and an accurate picture helps your provider choose the right medication and dose.
After screening, your provider will do a clinical interview. They’ll want to rule out other causes of your symptoms (thyroid problems, medication side effects, substance use) and understand whether you’re dealing mainly with depression, mainly with anxiety, or both. That distinction matters for treatment choices, though the good news is that the most commonly prescribed medications work for both conditions.
When Anxiety and Depression Show Up Together
If you have both, you’re in the majority. Among patients diagnosed with major depression, roughly 70% also meet criteria for generalized anxiety disorder.7PubMed Central. Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder Having both tends to make each condition worse: people with the combination report poorer sleep, less social support, and lower quality of life than those with depression alone. This overlap actually simplifies medication choice in one way, since SSRIs and SNRIs are effective for both, but it also means your provider should be monitoring both sets of symptoms, not just one.
The Medications You’re Most Likely to Be Prescribed
For most people, the first prescription will be an SSRI (selective serotonin reuptake inhibitor). Common names include sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), and paroxetine (Paxil). These are first-line treatments for both depression and anxiety because they’re generally effective, well-tolerated, and have decades of safety data behind them. Research into how SSRIs work at the symptom level has found that their strongest direct effects are on depressed mood and psychic anxiety, with measurable improvement in mood appearing as early as the first week and anxiety relief building over the following weeks.8Translational Psychiatry. The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective
SNRIs (serotonin-norepinephrine reuptake inhibitors) like venlafaxine (Effexor) and duloxetine (Cymbalta) are another common option. They work on two chemical messengers instead of one and are considered equally appropriate as first-line treatment. Some evidence suggests SNRIs may have a slight clinical edge in certain anxiety disorders.9PubMed. Serotonin norepinephrine reuptake inhibitors in anxiety disorders: a comprehensive review of their clinical efficacy Your provider might start with an SNRI if your depression includes prominent fatigue or pain, since the added norepinephrine activity can help with those symptoms.
Alternatives When SSRIs or SNRIs Are Not the Right Fit
Not everyone does well on SSRIs or SNRIs. Some people experience side effects they find intolerable, with sexual dysfunction being one of the most common complaints. Bupropion (Wellbutrin) is an antidepressant that works through different brain pathways and is far less likely to cause sexual side effects, affecting roughly 10% or fewer of patients compared to the higher rates seen with SSRIs.10PubMed. Antidepressant-induced sexual dysfunction Mirtazapine (Remeron) also has a low rate of sexual side effects and can be helpful if insomnia or poor appetite are significant problems, since it tends to be sedating and can increase appetite. The catch with bupropion is that it doesn’t treat anxiety well on its own and can sometimes worsen it, so it’s a better fit for depression without a major anxiety component.
For anxiety specifically, your provider may consider medications beyond antidepressants. Buspirone is a non-addictive anti-anxiety medication that works gradually, similar in timeline to an antidepressant. Hydroxyzine (an antihistamine with anti-anxiety properties) is another option. A Cochrane systematic review found hydroxyzine was more effective than placebo for generalized anxiety and comparable in efficacy to both benzodiazepines and buspirone.11PubMed Central. Hydroxyzine for generalised anxiety disorder Hydroxyzine works faster than buspirone, often within an hour, and has no addiction potential, which makes it useful for as-needed anxiety relief.
Benzodiazepines and Why They’re Prescribed Cautiously
If you’ve heard of Xanax (alprazolam), Ativan (lorazepam), or Klonopin (clonazepam), these are benzodiazepines. They work quickly, often within 30 minutes, and can be genuinely helpful for acute anxiety or panic. But they carry a real risk of dependence, and regular use can lead to physical withdrawal symptoms that, in severe cases, can be dangerous.12PubMed Central. Benzodiazepines: Uses, Dangers, and Clinical Considerations
That said, the picture is not entirely black and white. Recent expert discussion has acknowledged that for well-defined anxiety disorders like panic disorder, social anxiety, and generalized anxiety, benzodiazepines can sometimes be appropriate for longer-term maintenance at stable doses, as long as there’s clear ongoing benefit and the patient is also engaged in therapy to address the behavioral components of anxiety.13The Journal of Clinical Psychiatry. Resolving the Paradox of Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice Guidelines In practice, most providers reserve benzodiazepines as a short-term bridge while an SSRI or SNRI builds up to full effect, or for occasional use during acute episodes. If a provider offers you a benzodiazepine as your only treatment with no plan to start something longer-acting, that’s worth questioning.
How Long Before You Feel a Difference
This is the part that frustrates most people. Antidepressants typically take weeks to reach their full effect.14PubMed Central. The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments Research on fluoxetine specifically found that among people who eventually responded, over half experienced the beginning of their response by week two, and about 80% by week four.15PubMed. Timing of onset of antidepressant response with fluoxetine treatment But “beginning of response” doesn’t mean full improvement. Most guidelines recommend giving a medication at least six to eight weeks at an adequate dose before concluding it isn’t working.
Many people don’t respond to the first medication they try.16PubMed. Predicting treatment response to antidepressant medication using early changes in emotional processing This doesn’t mean medication won’t work for you; it usually means you need a different one or a dose adjustment. The process can feel discouraging, but staying in contact with your prescriber during the first few months is critical. Don’t stop a medication abruptly because you don’t feel better after a week or two, and don’t suffer through intolerable side effects without calling your provider.
Telehealth as an Access Route
If getting to an in-person appointment is a barrier, whether because of scheduling, transportation, location, or simply the activation energy required when you’re depressed, telehealth is a legitimate path to a prescription. Video and phone visits expanded dramatically during the pandemic and have stayed in place. Research has found telehealth is used for therapy access, care coordination, and medication adherence support among people with depression and anxiety.17PubMed Central. Use of Telehealth to Address Depression and Anxiety in Low-income US Populations: A Narrative Review
A word of caution, though. The boom in digital mental health startups has created a landscape where quality varies. Some online platforms are staffed by appropriately credentialed providers who follow evidence-based prescribing guidelines. Others raise concerns about self-diagnosis, inadequate evaluation, and prescribing that may not meet the standard of care.18PubMed Central. Telepsychiatry in an Era of Digital Mental Health Startups Look for services that use licensed prescribers (physicians, psychiatrists, or psychiatric nurse practitioners), that offer real diagnostic interviews rather than a checklist you fill out yourself, and that provide follow-up appointments, not just a one-time prescription.
Why Combining Medication with Therapy Works Better
Medication alone is helpful, but the evidence consistently favors combining it with psychotherapy. A meta-analysis across studies of depression, panic disorder, and OCD found that combined treatment produced a moderately large additional benefit over medication alone, with a number needed to treat of roughly four, meaning for every four people who add therapy to their medication, one additional person achieves a meaningfully better outcome.19PubMed Central. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis Cognitive behavioral therapy (CBT) is the most studied type for both conditions, and it’s available through many of the same access points as medication, including telehealth. If your provider prescribes medication without discussing therapy, ask about it.
Stopping Medication Safely
When things are going well, many people wonder when they can stop. The decision should always be made with your provider, but the process of stopping matters as much as the timing. Abruptly discontinuing an antidepressant can trigger a withdrawal syndrome that includes dizziness, nausea, irritability, brain zaps (a distinctive electric-shock-like sensation), and flu-like symptoms. This is well-documented and happens frequently enough that providers should discuss it proactively.20PubMed Central. A review of the management of antidepressant discontinuation symptoms
Standard guideline advice has been to taper over two to four weeks, but research suggests that’s often too fast. Withdrawal symptoms can be severe with short tapers, sometimes compelling people to restart medication. Longer tapers over months, gradually reducing to doses well below the usual minimum, have shown greater success in reducing withdrawal symptoms.21The Lancet Psychiatry. Tapering of SSRI treatment to facilitate discontinuation Withdrawal symptoms can also mimic a relapse of the underlying condition, which sometimes leads to people staying on medication longer than they need to. If you start feeling worse during a taper, talk to your provider about whether you’re experiencing withdrawal or a return of the original problem, since the management is quite different.
Insurance, Cost, and Coverage Barriers
Most generic SSRIs and SNRIs are inexpensive, often under $20 per month even without insurance, and are covered by virtually every health plan. The cost issue surfaces with brand-name or newer medications. As of the latest data available, the majority of commercial health plans placed newer branded antidepressants on higher copayment tiers, and over half used tier-3 or tier-4 pricing as their only form of restriction.22PubMed Central. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans High copays and prior authorization requirements can be a real barrier if your provider wants you on something newer.
If cost is a concern, tell your provider upfront. In many cases, a generic SSRI or SNRI is the evidence-based first choice anyway, and starting there makes clinical sense regardless of your insurance situation. Patient assistance programs, manufacturer coupons, and pharmacy discount cards (like GoodRx) can also reduce out-of-pocket costs. Community health centers and federally qualified health centers offer sliding-scale fees for both the visit and the medication.
When Standard Treatments Don’t Work
If you’ve tried two or more medications at adequate doses for adequate durations without improvement, your provider may describe your condition as treatment-resistant. This doesn’t mean nothing will help. It means the more readily available options haven’t worked, and it’s time to consider other approaches.
Ketamine and its derivative esketamine (Spravato, an FDA-approved nasal spray) represent a genuinely different mechanism from traditional antidepressants and have shown rapid-onset effects in treatment-resistant depression.23PubMed Central. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation Esketamine is administered in a certified clinic under observation and is typically used alongside an oral antidepressant, not on its own.24PubMed Central. The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review Access remains limited by cost and availability, but insurance coverage for esketamine has expanded. Other options at this stage include augmentation strategies (adding a second medication like an atypical antipsychotic or lithium to your existing antidepressant), electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS).
Supplements That Can Cause Trouble
One of the most dangerous gaps in mental health treatment is the supplement conversation that never happens. St. John’s wort is widely available over the counter and marketed for mood support. Many people start taking it before or alongside a prescription antidepressant without telling their provider. This combination can be dangerous. St. John’s wort significantly alters how SSRIs are metabolized and increases the risk of serotonin syndrome, a potentially life-threatening condition characterized by agitation, rapid heart rate, high body temperature, and muscle rigidity.25PubMed Central. The Effects of St. John’s Wort and its Interactions with SSRI’s Because it’s a supplement and not a prescription drug, providers often don’t think to ask about it, and patients don’t think to mention it.26PubMed. Molecular mechanisms underlying St. John’s wort drug interactions
The same principle extends to other supplements with serotonergic activity, including 5-HTP and SAMe. If you’re taking or considering any supplement for mood or anxiety, bring the bottle to your appointment or at least mention it by name. Your provider cannot account for interactions they don’t know about.
Pharmacogenetic Testing
You may have seen ads for genetic tests that claim to tell you which antidepressant will work best for you. These pharmacogenetic tests analyze variations in genes involved in drug metabolism, the idea being that if your body processes a particular drug unusually fast or slow, knowing that upfront could spare you weeks of trial and error. The concept is sound, and there is real evidence that these genetic variations affect how people respond to medications.27PubMed Central. Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
The honest state of the science, though, is mixed. While pharmacogenetic testing can be informative in specific situations, particularly in predicting who’s likely to experience side effects, the data don’t yet support its routine use for choosing among antidepressants.28PubMed Central. Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing If you’ve tried several medications and had unusual side effects or no response, asking about pharmacogenetic testing is reasonable. But paying out of pocket for a test before your first prescription is probably premature.
Considerations for Older Adults
If you’re over 65 or helping a parent navigate this process, the medication landscape shifts somewhat. The same drug classes are used, but the choice among them and the dosing require more care. Older adults metabolize drugs differently, take more medications overall (raising the risk of interactions), and are more sensitive to certain side effects. Anticholinergic medications, which include some older antidepressants and many common over-the-counter drugs, can worsen cognition and should generally be avoided or tapered off. Benzodiazepines carry higher fall risk in older adults, and tapering off them safely, rather than starting them, is often a treatment goal in itself.29PubMed Central. Optimizing treatment for older adults with depression SSRIs remain first-line for this age group, with SNRIs, bupropion, and mirtazapine as alternatives when the first choice doesn’t work. The key practical point: doses should start low and be increased gradually, and the prescriber should review all current medications for interactions and cognitive side effects.